Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2007
06/28/2007WO2007071936A1 Heterocyclic compounds, their preparation and their use as antibacterials
06/28/2007WO2007071915A2 Pharmaceutical product comprising porous silicon
06/28/2007WO2007071876A1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology
06/28/2007WO2007071875A2 Use of ceramides for depigmenting the skin
06/28/2007WO2007071861A2 Compositions including at least one retinoid compound and at least one anti-irritant compound and uses thereof
06/28/2007WO2007071766A2 Phenoxy acetic acids as ppar delta activators
06/28/2007WO2007071753A2 S-omeprazole magnesium
06/28/2007WO2007071752A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors
06/28/2007WO2007071738A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors
06/28/2007WO2007071733A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
06/28/2007WO2007071728A1 Hydantoins with insulinotropic action
06/28/2007WO2007071721A2 Ginger extract for inhibiting human drug transporters
06/28/2007WO2007071708A2 Ginger fraction for inhibiting human cyp enzymes
06/28/2007WO2007071691A1 3- (4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] 0xy} phenyl) -1-piperidinyl] carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
06/28/2007WO2007071662A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
06/28/2007WO2007071658A2 Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
06/28/2007WO2007071653A1 Use of aminoalcohol derivatives for the treatment of overactive bladder
06/28/2007WO2007071648A1 Crystalline form of vinflunine ditartrate
06/28/2007WO2007071646A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases
06/28/2007WO2007071639A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
06/28/2007WO2007071638A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor
06/28/2007WO2007071625A2 Cyclic peptides and their use in treating advanced stage neuroblastoma
06/28/2007WO2007071621A1 Heteroarylpyrrolopyridinones active as kinase inhibitors
06/28/2007WO2007071605A1 The use of st1898 for the treatment of restenosis
06/28/2007WO2007071603A1 Treatment of drug-resistant tumors
06/28/2007WO2007071598A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives
06/28/2007WO2007071576A1 New salt and polymorph of dpp-iv inhibitor
06/28/2007WO2007071456A1 Fluorenes and carbazoles as ligands of the ep2 receptor
06/28/2007WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
06/28/2007WO2007071453A1 Organophosphoric derivatives useful as anti-parasitic agents
06/28/2007WO2007071452A1 Synephrine derivatives useful as anti-inflammatory agents
06/28/2007WO2007071444A2 Esomeprazole arginine
06/28/2007WO2007071443A1 Inhibitors of ccr9 activity
06/28/2007WO2007071441A1 Inhibitors of ccr9 activity
06/28/2007WO2007071440A1 Inhibitors of ccr9 activity
06/28/2007WO2007071434A1 Antiviral 2-carboxy-thiophene compounds
06/28/2007WO2007071420A1 Bursting pellets
06/28/2007WO2007071415A1 Bis-platinum complexes with antitumor activity
06/28/2007WO2007071402A1 Means and methods for the treatment and prevention of allergic diseases
06/28/2007WO2007071400A1 Pyrazine derivatives as epithelial sodium channel blocker
06/28/2007WO2007071393A2 Sulphonamidoaniline derivatives being janus kinases inhibitors
06/28/2007WO2007071379A1 PYRROLO [l,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF
06/28/2007WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/28/2007WO2007071357A2 Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid
06/28/2007WO2007071348A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer
06/28/2007WO2007071313A2 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
06/28/2007WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
06/28/2007WO2007071205A2 A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy
06/28/2007WO2007071199A1 2,4-disubstituted amido-6-substituted-[1,3,5]triazine or 1,3-pyrimidine compounds, their processes for preparation, their pharmaceutical compositions and uses thereof
06/28/2007WO2007071159A1 The use of anthraquinone derivatives for preparation of medicaments against influenza and “bird flu” viruse
06/28/2007WO2007071158A1 Antiperspirant compositions
06/28/2007WO2007071071A1 Oligonucleotides and antiviral uses thereof
06/28/2007WO2007071069A1 Transcription factor decoy oligodeoxynucleotides having multiple cis elements
06/28/2007WO2007071055A1 Compositions and methods for modulating gated ion channels
06/28/2007WO2007071053A1 Markers for memory t cells and uses thereof
06/28/2007WO2007071052A1 Treatment of respiratory diseases
06/28/2007WO2007071045A1 Catecholamine regulated protein
06/28/2007WO2007071038A2 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers
06/28/2007WO2007071036A1 Emulsions comprising non-esterified phytosterols in the aqueous phase
06/28/2007WO2007071035A1 Heterocyclic amide derivatives as calcium channel blockers
06/28/2007WO2007071023A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/28/2007WO2007071012A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
06/28/2007WO2007070986A1 Flavones
06/28/2007WO2007070985A1 Tiglien-3-one derivatives
06/28/2007WO2007070984A1 Spiroketals
06/28/2007WO2007070983A1 Transdermal delivery of pharmaceutical agents
06/28/2007WO2007070981A1 Compounds having cytokine modulating properties
06/28/2007WO2007070961A1 Mif inhibitors
06/28/2007WO2007070947A1 Antibacterial agents
06/28/2007WO2007059154A3 Treatment of cancers with acquired resistance to kit inhibitors
06/28/2007WO2007059125A3 Hiv integrase inhibitors
06/28/2007WO2007056284A3 Polycationic viscoelastic compositions
06/28/2007WO2007054573A3 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and egfr inhibitors or pyrimidine analogues
06/28/2007WO2007054444A3 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
06/28/2007WO2007054436A3 Thiazolo [4 , 5-c] pyridine derivatives as mglu5 receptor antagonists
06/28/2007WO2007053698A3 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
06/28/2007WO2007053499A3 Compounds useful as antagonists of ccr2
06/28/2007WO2007053353A3 Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands
06/28/2007WO2007050576A3 A method of preparing a 4-oxo-1- (3 substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3- carboxamide phosphodiesterase-4 inhibitor
06/28/2007WO2007048066A3 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
06/28/2007WO2007048065A3 Pyrimidinones as casein kinase ii (ck2) modulators
06/28/2007WO2007047919A3 Treatment of restenosis and stenosis with dasatinib
06/28/2007WO2007047687A3 Compositions and methods for prolonging survival of platelets
06/28/2007WO2007047372A3 Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
06/28/2007WO2007045060B1 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production
06/28/2007WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
06/28/2007WO2007044085A3 Heteroaryl compounds and their uses as therapeutic agents
06/28/2007WO2007042784A3 Pyrimidin-4-yl-3, 4-dihydr0-2h- pyrrolo [1, 2a] pyrazin-1-one compounds
06/28/2007WO2007041697A3 Hydrogenated pyrido-indole compounds for the treatment of huntington ' s disease
06/28/2007WO2007039124A3 Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness
06/28/2007WO2007038551A3 Use of ibudilast for treating drug and behavioral addictions
06/28/2007WO2007038435A3 Estriol therapy for autoimmune and neurodegenerative diseases and disorders
06/28/2007WO2007035430A3 Process for the preparation of benzo [e] [1,2,4] triazepin-2-one derivatives
06/28/2007WO2007034024A3 Treatment of symptoms of parkinson' s disease
06/28/2007WO2007033774A3 Use of inhibitors of the na+/h+ exchanger, subtype 5 (nhe5), to improve memory retention
06/28/2007WO2007033292A3 Combination therapy for controlled carbohydrate digestion
06/28/2007WO2007026920A3 Amide derivatives as rock inhibitors
06/28/2007WO2007026166A3 Method of combating infection
06/28/2007WO2007025275A3 Control of induced elevated intraocular pressure
06/28/2007WO2007025186A3 Hydrazone agents to treat cutaneous lesions
1 ... 3689 3690 3691 3692 3693 3694 3695 3696 3697 3698 3699 3700 3701 3702 3703 3704 3705 3706 3707 3708 3709 ... 7860